Hans joined SEB Venture Capital in 1997. Prior to that he had various positions within SEB’s asset management activities during twelve years.
Before that, he spent eight years of industrial strategic planning and business control within Swedish Match and abroad. Over the years he has had board of director positions in several different listed companies. Hans focuses on investments in the intersection between Life Science and Technology including cleantech. Hans has also, through his engagement with Venture Capital’s investment in Mamma Mia, gained valuable experience within the entertainment business.
Hans has an MBA from Stockholm University and is a Certified Financial Analyst (CFA). Hans is currently a board member of Cobolt AB, Diakrit International Ltd, Xylophane AB, KTH Seed Capital & KTH Chalmers Capital KB and Index Pharmaceuticals AB.
Phone: +46 8 763 79 04 Cell: +46 702 65 79 04 E-mail: email@example.com